NEW YORK (GenomeWeb) — Adarza Biosystems said today that it has closed a $5 million Series B funding round.

The company plans to use the proceeds to expand the production capacity of its manufacturing facility in St. Peters, Missouri, and to launch its first immunoassay instrument platform. Adarza also said it will accelerate the development of assays targeting biological analytes, including cytokines, antigens, and small molecules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.